Merger: absorbed by PHARMACIE BUSTIN
Dissolution of the company · Dissolved without liquidation · Hidden nameVisible after signing in holds 100% of the shares · General meeting of 28-06-2024 · Gazette deed
Merger proposal: to be absorbed by PHARMACIE BUSTINName after signing inVisible after signing in holds all the shares · Gazette deed
Registered office moved from Saint-Nicolas to Verviers
The registered office moved from Place Emile Vandervelde, 4420 SAINT-NICOLAS to rue Mangombroux 161, 4800 VERVIERS · Name hiddenVisible after signing in changes role from daily management delegate to sole director · Hidden nameVisible after signing in resigns as daily management delegate · Gazette deed
Demerger: BIOPHA splits off to FRANCOISE DISCRY
Capital decrease of €47,999.27 · Name after signing inVisible after signing in resigns as director · Name hiddenVisible after signing in reappointed as director · General meeting of 23-12-2021 · Gazette deed
“L’achat, la vente, la préparation de produits pharmaceutiques, diététiques, homéopathiques,” (deed in French)From the articles, 6 activitiesNo NACE code in the KBO
BIOPHA had an average of 1.5 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of BIOPHA?
The turnover in financial year 2023 is about €580,000. This figure is estimated from the gross margin of €226,367 and 1,394 comparable companies of the same size. It probably lies between €350,000 and €1.1m. It is a rough estimate.
Is BIOPHA profitable?
In financial year 2023, BIOPHA made a profit of €64,953.
Where can I find the annual accounts of BIOPHA?
BIOPHA filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2023.